COVID-19

COVID-19

Computationally Designed mRNA-Launched Protein Nanoparticle Immunogens Show Promise in Vaccine Development

Researchers from Stanford University School of Medicine have made a breakthrough in vaccine development, demonstrating the effectiveness of computationally designed protein nanoparticle immunogens delivered through messenger RNA (mRNA). The study, which has been peer-reviewed, showcases the potential of combining mRNA vaccines with protein nanoparticle vaccines to elicit strong immune responses.